Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Histone deacetylases modulate resistance to the therapy in lung cancer
Estefanía Contreras-Sanzón, Heriberto Prado-Garcı́a, Susana Romero-García, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 21

Showing 21 citing articles:

The Emerging Role of Epigenetics in Metabolism and Endocrinology
Belay Zeleke Sibuh, Sameer Quazi, Hrithika Panday, et al.
Biology (2023) Vol. 12, Iss. 2, pp. 256-256
Open Access | Times Cited: 13
Epigenetic regulation by quercetin: a comprehensive review focused on its biological mechanisms
Jinfeng Zhu, Xiaju Cheng, Nenad Naumovski, et al.
Critical Reviews in Food Science and Nutrition (2023) Vol. 65, Iss. 4, pp. 627-646
Closed Access | Times Cited: 11
POxload: Machine Learning Estimates Drug Loadings of Polymeric Micelles
Josef Kehrein, Alex Bunker, Robert Luxenhofer
Molecular Pharmaceutics (2024) Vol. 21, Iss. 7, pp. 3356-3374
Closed Access | Times Cited: 4
c-FLIP/Ku70 complex; A potential molecular target for apoptosis induction in hepatocellular carcinoma
Yasamin Haghir-Sharif-Zamini, Arezoo Khosravi, Moustapha Hassan, et al.
Archives of Biochemistry and Biophysics (2025), pp. 110306-110306
Closed Access
Epigenetic code underlying EGFR-TKI resistance in non-small-cell lung cancer: elucidation of mechanisms and perspectives on therapeutic strategies
Xin Yao, Chundi Gao, Changgang Sun, et al.
Drug Discovery Today (2025), pp. 104321-104321
Closed Access
New and Effective Inhibitor of Class I HDACs, Eimbinostat, Reduces the Growth of Hematologic Cancer Cells and Triggers Apoptosis
Pavel Spirin, Valeria Vedernikova, Tatsiana Volkava, et al.
Pharmaceutics (2025) Vol. 17, Iss. 4, pp. 416-416
Open Access
HDAC5, an early osimertinib-responsive gene, is a novel therapeutic target for the drug resistance in EGFR-mutant lung adenocarcinoma cells
Hanbing Lyu, Akihiko Ishimura, Ryusuke Suzuki, et al.
Biochemistry and Biophysics Reports (2025) Vol. 42, pp. 102016-102016
Closed Access
Epigenetic regulation of pulmonary inflammation
Shama Ahmad, Xiao Lu Zhang, Aftab Ahmad
Seminars in Cell and Developmental Biology (2023) Vol. 154, pp. 346-354
Open Access | Times Cited: 9
State of the art CRISPR-based strategies for cancer diagnostics and treatment
Emma Di Carlo, Carlo Sorrentino
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 2
Sodium butyrate supresses malignant human mast cell proliferation, downregulates expression of KIT and promotes differentiation
Clayton MacDonald, Hui Qian, Priyanka Pundir, et al.
Frontiers in Allergy (2023) Vol. 4
Open Access | Times Cited: 5
Water-soluble 4-(dimethylaminomethyl)heliomycin exerts greater antitumor effects than parental heliomycin by targeting the tNOX-SIRT1 axis and apoptosis in oral cancer cells
Atikul Islam, Yu-Chun Chang, Xiao-Chi Chen, et al.
eLife (2024) Vol. 12
Open Access | Times Cited: 1
Identification of chemoresistance targets in doxorubicin-resistant lung adenocarcinoma cells using LC-MS/MS-based proteomics
Nuzhat Bano, KM Kainat, Mohammad Imran Ansari, et al.
Journal of Chemotherapy (2024), pp. 1-15
Closed Access | Times Cited: 1
Structure, function and stability analysis on potential deleterious mutation ensemble in glyceraldehyde 3-phosphate dehydrogenase (GAPDH) for early detection of LUAD
Pearl John, C. Sudandiradoss
Life Sciences (2024) Vol. 358, pp. 123127-123127
Closed Access | Times Cited: 1
Synthesis and anticancer evaluation of acetylated-lysine conjugated gemcitabine prodrugs
Mengmeng Wang, Kunyu Qu, Peipei Zhao, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 8, pp. 1572-1580
Open Access | Times Cited: 3
Water-soluble 4-(dimethylaminomethyl)heliomycin exerts greater antitumor effects than parental heliomycin by targeting the tNOX-SIRT1 axis and apoptosis in oral cancer cells
Atikul Islam, Yu-Chun Chang, Xiao-Chi Chen, et al.
(2024)
Open Access
Author Response: Water-soluble 4-(dimethylaminomethyl)heliomycin exerts greater antitumor effects than parental heliomycin by targeting the tNOX-SIRT1 axis and apoptosis in oral cancer cells
Atikul Islam, Yu-Chun Chang, Xiao-Chi Chen, et al.
(2024)
Open Access
Curcumin blunts epithelial-mesenchymal transition to alleviate invasion and metastasis of prostate cancer through the JARID1D demethylation
Qinghua Xie, Yaohua Hu, Chenyang Zhang, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access
MYST2 histone acetyltransferase promotes lung adenocarcinoma progression by regulating the p38 MAPK signaling pathway
Zhiang Huang, Wanru Zhang, Ping Wang, et al.
Translational Oncology (2024) Vol. 51, pp. 102218-102218
Closed Access
Water-soluble 4-(dimethylaminomethyl)heliomycin exerts greater antitumor effects than parental heliomycin by targeting the tNOX-SIRT1 axis and apoptosis in oral cancer cells
Atikul Islam, Yu-Chun Chang, Xiao-Chi Chen, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 1
Secretion of acetylated amino acids by drug-induced cancer cells: perspectives on metabolic-epigenetic alterations
Nilesh Kumar Sharma, Sachin C. Sarode, Anjali Bahot, et al.
Epigenomics (2023) Vol. 15, Iss. 19, pp. 983-990
Closed Access | Times Cited: 1
Water-soluble 4-(dimethylaminomethyl)heliomycin exerts greater antitumor effects than parental heliomycin by targeting the tNOX-SIRT1 axis and apoptosis in oral cancer cells
Atikul Islam, Yu-Chun Chang, Xiao-Chi Chen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top